$3.92
0.06[1.55%]
At close: Apr 26
$3.92
0[0.00%]
After Hours: 4:02PM EDT
G1 Therapeutics
(NASDAQ:GTHX)G1 Therapeutics Stock (NASDAQ:GTHX), Insider Trading Activity
G1 Therapeutics: Insider buying and selling updated today.
Insider Shares Owned
2.260M
Insider Percentage Owned
4.33%
Institutional Shares Held
4.414M
Institutional Percentage Held
8.46%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2024 | John Umstead V | CHIEF FINANCIAL OFFICER | -6.547K | $3.02 | -$19.75K | SELL | -5.02% | 123.896K | Mar 18 | View |
| Feb 13, 2024 | Rajesh Malik | CHIEF MEDICAL OFFICER | 0 | $2.46 | -$123.56K | SELL-OPTIONS | 0.00% | 169.938K | Feb 12 | View |
| Jan 08, 2024 | John Umstead V | CHIEF FINANCIAL OFFICER | 36.557K | $3.09 | -$2.30K | GRANT | 38.94% | 130.443K | Jan 03 - Jan 04 | View |
| Jan 08, 2024 | Rajesh Malik | CHIEF MEDICAL OFFICER | 33.56K | $3.08 | -$11.54K | GRANT | 24.61% | 169.938K | Jan 03 - Jan 04 | View |
| Jan 08, 2024 | Andrew Perry | CHIEF COMMERCIAL OFFICER | 31.157K | $3.12 | -$7.53K | GRANT | 55.69% | 87.102K | Jan 03 | View |
| Jan 08, 2024 | Jack John Bailey Jr | PRESIDENT AND CEO | 89.014K | $3.12 | -$36.45K | GRANT | 22.22% | 489.594K | Jan 03 | View |
| Jan 08, 2024 | Mark Avagliano | CHIEF BUSINESS OFFICER | 40.679K | $3.09 | -$12.60K | GRANT | 52.72% | 117.834K | Jan 03 - Jan 04 | View |
| Jan 08, 2024 | TERRY MURDOCK | CHIEF OPERATING OFFICER | 33.56K | $3.08 | -$11.54K | GRANT | 47.89% | 103.638K | Jan 03 - Jan 04 | View |
| Jan 02, 2024 | Jack John Bailey Jr | PRESIDENT AND CEO | -32.983K | $3.27 | -$108.01K | SELL | -7.61% | 400.58K | Jan 02 | View |
| Dec 13, 2023 | Rajesh Malik | CHIEF MEDICAL OFFICER | 0 | $1.89 | -$103.44K | SELL-OPTIONS | 0.00% | 136.378K | Dec 11 | View |
| Aug 10, 2023 | Mark Velleca | 0 | $1.19 | -$96.82K | SELL-OPTIONS | 0.00% | 116K | Aug 08 | View | |
| Jul 07, 2023 | Andrew Perry | CHIEF COMMERCIAL OFFICER | -355 | $2.45 | -$871.06 | SELL | -0.63% | 55.945K | Jul 05 | View |
| Jul 07, 2023 | TERRY MURDOCK | CHIEF OPERATING OFFICER | -1.361K | $2.45 | -$3.34K | SELL | -1.91% | 70.078K | Jul 05 | View |
| Jul 07, 2023 | Rajesh Malik | CHIEF MEDICAL OFFICER | -1.361K | $2.45 | -$3.34K | SELL | -0.99% | 136.378K | Jul 05 | View |
| Jul 07, 2023 | Jack John Bailey Jr | PRESIDENT AND CEO | -2.719K | $2.45 | -$6.67K | SELL | -0.62% | 433.563K | Jul 05 | View |
| Jan 05, 2023 | Jennifer Moses | CFO | 19.932K | $5.52 | -$13.08K | GRANT | 52.61% | 57.82K | Jan 03 - Jan 05 | View |
| Jan 05, 2023 | TERRY MURDOCK | CHIEF OPERATING OFFICER | 15.532K | $5.52 | -$13.08K | GRANT | 74.29% | 36.439K | Jan 03 - Jan 05 | View |
| Jan 05, 2023 | Andrew Perry | CHIEF COMMERCIAL OFFICER | 15.28K | $5.58 | -$4.57K | GRANT | 253.82% | 21.3K | Jan 03 - Jan 04 | View |
| Jan 05, 2023 | Rajesh Malik | CHIEF MEDICAL OFFICER | 15.532K | $5.52 | -$13.08K | GRANT | 17.81% | 102.739K | Jan 03 - Jan 05 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.